当前位置: X-MOL 学术Cytom. Part B Clin. Cytom. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
FMOD expression in whole blood aids in distinguishing between chronic lymphocytic leukemia and other leukemic lymphoproliferative disorders. A pilot study.
Cytometry Part B: Clinical Cytometry ( IF 3.4 ) Pub Date : 2020-06-12 , DOI: 10.1002/cyto.b.21890
Marc Sorigue 1 , Jordi Junca 1 , Christelle Ferra 2 , Silvia Marce 1 , Neus Ruiz-Xivillé 1 , Laia Pinyol 1 , Marta Cabezon 1 , Andrea Espasa 1 , Diana Dominguez 1 , Laia Lopez-Viaplana 3 , Rocio Ruiz 4 , Joan Buch 5 , Esther Plensa 3 , Silvia-Zdenka Mostacedo 5 , Jessica Aranda 4 , Sara Vergara 1 , Minerva Raya 1 , Isabel Granada 1 , Gustavo Tapia 6 , Jose-Tomas Navarro 1 , Silvia Beà 7, 8, 9 , Lurdes Zamora 1
Affiliation  

Within the hematopoietic compartment, fibromodulin (FMOD) is almost exclusively expressed in chronic lymphocytic leukemia (CLL) lymphocytes. We set out to determine whether FMOD could be of help in diagnosing borderline lymphoproliferative disorders (LPD).

中文翻译:

FMOD 在全血中的表达有助于区分慢性淋巴细胞白血病和其他白血病淋巴组织增生性疾病。一项试点研究。

在造血区室中,纤维调节蛋白 (FMOD) 几乎只在慢性淋巴细胞白血病 (CLL) 淋巴细胞中表达。我们着手确定 FMOD 是否有助于诊断临界淋巴组织增生性疾病 (LPD)。
更新日期:2020-06-12
down
wechat
bug